Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

Biocept to Present at The MicroCap Conference on April 4th in New York City

PR Newswire March 31, 2017

Biocept Announces Pricing of $9.3 Million Financing

PR Newswire March 28, 2017

Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer Healthcare Conference

PR Newswire March 20, 2017

20 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  March 15, 2017

Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference

PR Newswire March 15, 2017

Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)

PR Newswire March 14, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  March 8, 2017

Biocept to Present at the 29th Annual ROTH Conference

PR Newswire March 8, 2017

Medical Laboratories Stocks Under Scanner -- Great Basin Scientific, Biocept, Quintiles IMS, and OpGen

PR Newswire March 8, 2017

Biocept Reports Fourth Quarter and Full Year 2016 Financial Results

PR Newswire March 7, 2017

Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 7, 2017

PR Newswire February 21, 2017

Biocept Appoints Michael Terry Senior Vice President Commercial Operations

PR Newswire February 15, 2017

10 Biggest Mid-Day Losers For Monday

Benzinga.com  February 13, 2017

20 Biggest Mid-Day Gainers For Thursday

Benzinga.com  February 9, 2017

Biocept's CEO Issues Letter to Stockholders

PR Newswire February 9, 2017

Biocept to Present at the 19th Annual BIO CEO and Investor Conference

PR Newswire February 6, 2017

How These Medical Research Stocks are Faring? -- Quintiles IMS, OpGen, Novadaq Technologies, and Biocept

PR Newswire January 24, 2017

15 Biggest Mid-Day Gainers For Thursday

Benzinga.com  January 19, 2017

Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells

PR Newswire January 19, 2017

12 Biggest Mid-Day Losers For Friday

Benzinga.com  January 13, 2017